All these results suggest that gender regulates the biological clock significantly differently in males and females, and in-depth studies are needed to explore the mechanisms behind gender differences that affect CRC morbidity and mortality, and to provide a gender-differentiated approach to disease prevention, diagnosis, and treatment. The gene discussed is CLOCK; the disease is colorectal carcinoma.